Clinical Trials
5
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Conditions
- Lung Cancer Diagnosis
- First Posted Date
- 2023-11-08
- Last Posted Date
- 2025-08-05
- Lead Sponsor
- Freenome Holdings Inc.
- Target Recruit Count
- 20000
- Registration Number
- NCT06122077
- Locations
- πΊπΈ
Horizon Clinical Research Group, Houston, Texas, United States
πΊπΈScience 37, Los Angeles, California, United States
πΊπΈStamford Hospital, Stamford, Connecticut, United States
The Sanderson Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening
- Conditions
- Newly-diagnosed CancersNon-cancer Controls
- First Posted Date
- 2022-08-26
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- Freenome Holdings Inc.
- Target Recruit Count
- 788
- Registration Number
- NCT05516927
- Locations
- πΊπΈ
Crisp Regional Hospital, Cordele, Georgia, United States
πΊπΈSilver Cross Hospital and Medical centers, Orland Park, Illinois, United States
πΊπΈAdvocate Lutheran General Hospital, Park Ridge, Illinois, United States
The Vallania Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening
- Conditions
- Cancer
- First Posted Date
- 2022-02-24
- Last Posted Date
- 2025-08-22
- Lead Sponsor
- Freenome Holdings Inc.
- Target Recruit Count
- 7435
- Registration Number
- NCT05254834
- Locations
- πΊπΈ
Mercy Cancer Center, Merced, California, United States
πΊπΈCentral Alabama Research, Birmingham, Alabama, United States
πΊπΈAlabama Oncology, Birmingham, Alabama, United States
Prevention of Colorectal Cancer Through Multiomics Blood Testing
- Conditions
- Rectal CancerColon LesionAdenomaColon DiseasesColorectal CancerRectal DiseasesGastrointestinal Tract CancersColon NeoplasmPolypColon Cancer
- First Posted Date
- 2020-04-30
- Last Posted Date
- 2025-03-27
- Lead Sponsor
- Freenome Holdings Inc.
- Target Recruit Count
- 48995
- Registration Number
- NCT04369053
- Locations
- πΊπΈ
Gastroenterology Associates of New Jersey(2), Wayne, New Jersey, United States
πΊπΈGastroenterology Associates of New Jersey(8), Wayne, New Jersey, United States
πΊπΈPinnacle Research Group LLC, Anniston, Alabama, United States
AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test
- Conditions
- Colo-rectal CancerCancer ColonPolypsCancer, RectumNeoplasms,ColorectalPolyp of ColonAdenomaAdenoma Colon
- First Posted Date
- 2018-09-28
- Last Posted Date
- 2022-03-02
- Lead Sponsor
- Freenome Holdings Inc.
- Target Recruit Count
- 3275
- Registration Number
- NCT03688906
- Locations
- πΊπΈ
Clinical Research Associates, Huntsville, Alabama, United States
πΊπΈDel Sol Research Management, Tucson, Arizona, United States
πΊπΈDel Sol Research Management,, Tucson, Arizona, United States